Landec Corporation (LNDC)
Company Description
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally.
It operates through Lifecore, Curation Foods, and Other segments.
The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.
It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products.
This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets.
The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels.
Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.

Country | United States |
IPO Date | Feb 16, 1996 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 689 |
CEO | Albert Bolles |
Contact Details
Address: 5201 Great America Pkwy Ste 232 Santa Clara, California United States | |
Website | https://www.landec.com |
Stock Details
Ticker Symbol | LNDC |
Exchange | NASDAQ |
Fiscal Year | June - May |
Reporting Currency | USD |
CIK Code | 0001005286 |
CUSIP Number | 514766104 |
ISIN Number | US5147661046 |
Employer ID | 94-3025618 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
James G. Hall | Chief Executive Officer, Pres & Director |
John D. Morberg | Chief Financial Officer & Sec. |
Aaron Perlitsh | Director of Internal Audit & Chief Compliance Officer |
Dr. Albert D. Bolles Ph.D. | Pres of Curation Foods, Inc. |
Parker K. Javid | Vice President |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 29, 2025 | SCHEDULE 13D/A | [Amend] Filing |
May 28, 2025 | 4 | Filing |
May 22, 2025 | 4 | Filing |
May 16, 2025 | 4 | Filing |
May 12, 2025 | 4 | Filing |
May 07, 2025 | 4 | Filing |
Apr 16, 2025 | 8-K | Current Report |
Apr 16, 2025 | 4 | Filing |
Apr 16, 2025 | 3 | Filing |
Apr 10, 2025 | 8-K | Current Report |